MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Elenco Azioni・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Aperta

SettoreSettore sanitario

27.74 -0.72

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

27.07

Massimo

27.82

Metriche Chiave
By Trading Economics
Entrata	-28M 22M
Vendite	4.3M 244M
P/E Media del settore	9.926 56.063
Margine di Profitto	9.224
Dipendenti	293
EBITDA	-22M 52M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+47.53% upside

Dividendi
By Dow Jones
Utili prossimi	5 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	8.3M 1.6B
Apertura precedente	28.46
Chiusura precedente	27.74

Notizie sul Sentiment di mercato

By Acuity

72%

28%

324 / 349 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

29.8 / N/A Supporto e resistenza

Harmony Biosciences Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 apr 2026, 17:11 UTC

I principali Market Mover

Principali Notizie su Eventi

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2 apr 2026, 17:10 UTC

Principali Notizie su Eventi

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3 apr 2026, 00:00 UTC

Principali Notizie su Eventi

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2 apr 2026, 23:47 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2 apr 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2 apr 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2 apr 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2 apr 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2 apr 2026, 21:01 UTC

Principali Notizie su Eventi

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2 apr 2026, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks and Boyu Capital Finalize China JV

2 apr 2026, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

2 apr 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

2 apr 2026, 20:41 UTC

Utili

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 apr 2026, 20:32 UTC

Discorsi di Mercato

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2 apr 2026, 20:30 UTC

Acquisizioni, Fusioni, Takeovers

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 20:09 UTC

Discorsi di Mercato

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2 apr 2026, 20:01 UTC

Acquisizioni, Fusioni, Takeovers

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 19:46 UTC

Discorsi di Mercato

Is Oil the New GameStop? -- Market Talk

2 apr 2026, 19:35 UTC

Discorsi di Mercato

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2 apr 2026, 19:29 UTC

Acquisizioni, Fusioni, Takeovers

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 19:24 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2 apr 2026, 19:20 UTC

Discorsi di Mercato

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2 apr 2026, 19:01 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2 apr 2026, 19:00 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific: Agreement Reached With American Train Dispatchers Association

2 apr 2026, 18:24 UTC

Acquisizioni, Fusioni, Takeovers

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2 apr 2026, 17:44 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2 apr 2026, 17:32 UTC

Principali Notizie su Eventi

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2 apr 2026, 17:26 UTC

Utili

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 apr 2026, 17:17 UTC

Discorsi di Mercato

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2 apr 2026, 17:09 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Confronto tra pari

Modifica del prezzo

Harmony Biosciences Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

47.53% in crescita

Previsioni per 12 mesi

Media 41.25 USD 47.53%

Alto 62 USD

Basso 25 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Harmony Biosciences Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a Harmony Biosciences Holdings Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

29.8 / N/ASupporto e resistenza

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

324 / 349 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.